Specifically, one of the immune targets is programmed death-ligand PD-L1, and the efficient immune reaction against cancer by tumor infiltrating lymphocytes (TILs) has provided more relevant prognostic by observing PD-L1-mediated tumor immune escape. This evidence concerns the gene CD274 and cancer.